Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

The Cigna Group

Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Cigna (CI) Beat Estimates Again in Its Next Earnings Report?

BLOOMFIELD, Conn. , Oct. 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its third quarter 2025 financial results on Thursday, October 30, 2025, and will host a conference call the same day.

The Cigna Group's Third Quarter 2025 Earnings Release Details

CI expands coverage to Cleerly's AI cardiovascular imaging, boosting access, early detection and digital healthcare adoption.

Cigna to Support Cleerly's AI Cardiovascular Imaging Solutions

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Heartflow secures FDA clearance and Cigna coverage for its Next Gen Plaque Analysis, boosting accuracy and nationwide access.

HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis

DENVER--(BUSINESS WIRE)-- #AI--Cleerly, a leader in AI-based cardiovascular imaging, today announced that Cigna will begin covering Cleerly LABS Advanced Plaque Analysis effective October 1, 2025. The coverage decision makes Cigna the latest major insurer to recognize the clinical and economic value of Artificial Intelligence Enabled CT Based Quantitative Coronary Tomography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) technology for cardiovascular care. With more than 16 million covered lives, Cigna j.

Cigna Approves Coverage for Cleerly's AI Cardiovascular Imaging Technology

AI-Powered Heartflow Plaque Analysis to be Covered by Cigna Health Plans Nationwide AI-Powered Heartflow Plaque Analysis to be Covered by Cigna Health Plans Nationwide

Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform

Cigna provides a market-beating dividend with plenty of room for further growth. The company topped analysts' expectations for revenue and adjusted EPS in Q2. Cigna's A-rated balance sheet gives it the means to complete strategic bolt-on acquisitions.

Cigna: Pounce On This SWAN Bargain Now

The Medical-HMO industry benefits from strength in commercial plans, M&A and expected Medicare rate hikes, but rising costs, regulatory shifts and workforce shortages strain margins. CI and HUM are likely to navigate industry storms.

2 HMO Stocks Poised to Thrive Despite Escalating Medical Costs

Cigna said on Wednesday the percentage of employers paying for obesity drugs has remained flat year-over-year, though the health insurer still sees an uptick in demand for the wildly popular treatments.

Rate of employers covering weight-loss drugs is flat, Cigna says

BLOOMFIELD, Conn. , Sept. 10, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced that Brian Evanko, President and COO of The Cigna Group, and Ann Dennison, EVP and CFO of the Cigna Group will present at the Morgan Stanley 23rd Annual Global Healthcare Conference today, September 10, 2025, in New York, NY.

The Cigna Group Announces Appearance at the Morgan Stanley 23rd Annual Global Healthcare Conference

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (Sept. 2025)

Barclays raised the firm's price target on Cigna to $383 from $354 and keeps an Overweight rating on the shares. The firm adjusted estimates and targets in the managed care and healthcare facility group following a "volatile" Q2 earnings season. Group valuations have increased recently, which may be a sign that investor sentiment and estimates have bottomed out, the analyst tells investors in a research note. From here, Barclays sees a number of potential catalysts including September budget deals, final pricing for Medicare Advantage and Affordable Care Act plans and Medicare Advantage star ratings for the 2027 plans. Relative to estimates, the firm believes UnitedHealth (UNH) and CVS Health (CVS) offer the most near-term upside while Molina Healthcare (MOH) has the most downside risk. 30 Oct

Cigna price target raised to $383 from $354 at Barclays

Cigna Group's CI Evernorth Health Services announced on Tuesday a $3.5 billion investment in Shields Health Solutions, a specialty pharmacy management company.

Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers

Cigna Group's unit Evernorth Health on Tuesday said it is investing $3.5 billion in specialty pharmacy company Shields Health.

Cigna's Evernorth invests $3.5 billion in Shields

Investment Further Enhances Evernorth's Participation in  Growing Market for Specialty Medicine  BLOOMFIELD, Conn. , Sept. 2, 2025 /PRNewswire/ -- Evernorth Health Services ("Evernorth"), a subsidiary of The Cigna Group (NYSE: CI), today announced a $3.5 billion investment in Shields Health Solutions ("Shields" or the "Company"), a leading specialty pharmacy management company.

Evernorth Health Services Announces Investment in Shields Health Solutions

Cigna's stock drop after Q2 2025 is overdone; shares now trade at a 15% discount to their 5-year average, creating a compelling entry point. Despite mixed Q2 results and lower profit growth forecasts, my DCF model supports a fair value of $315 per share, implying 8.5% upside. Aggressive share buybacks and steady dividend growth enhance shareholder returns, while Cigna maintains strong cash flows and manageable debt.

Cigna: Market Pessimism Creates Value Opportunity

Lisa Gill, JP Morgan healthcare analyst, on “Worldwide Exchange,” says healthcare is at an inflection point, with UnitedHealth poised for long-term gains as big investors bet on a turnaround.

Gill: We're at a real inflection point for healthcare

Cigna offers a lower-risk profile after selling its Medicare business, avoiding Medicare headwinds impacting peers like UnitedHealth Group. However, the stock price has fallen alongside UNH. Recent earnings were strong, guidance was affirmed, and valuation is attractive, with Wall Street seeing up to 35% upside potential. Risks remain from medical inflation and PBM regulatory scrutiny, but Cigna's business mix provides more pricing power and operational flexibility than UNH.

Cigna: Looks More Interesting Here Than UnitedHealth Group

Real-time stock quote and overview for CI